GlassScriptPhysician profile
Martha Robinson
NPI 1104232289
$4,182.17
in general payments reported to CMS, 2019-2025
11 companies · $560 in 2025
The $560 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.91 · 2020: $122 · 2021: $41.64 · 2022: $2,020 · 2023: $589 · 2024: $835 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,983.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,979.97 | 2021-2025 | Red 72, Benchmark, Penumbra Coil 400 |
| Medtronic, INC. | $688.57 | 2024-2025 | Pipeline, Axium Primetm, Rist |
| Microvention, INC. | $583.04 | 2020-2024 | Lvis Junior, Stent, Web Aneurysm Embolization System |
| Stryker Corporation | $312.44 | 2021-2022 | |
| Depuy Synthes Sales INC. | $251.49 | 2023-2025 | Trufill, Embotrap, Emboguard |
| Astrazeneca Pharmaceuticals LP | $116.22 | 2024 | Andexxa |
| Siemens Medical Solutions USA, INC. | $96.49 | 2025 | Artis Icono Biplane |
| Abbott Laboratories | $64.91 | 2023 | Xact |
| Novartis Pharmaceuticals Corporation | $51.69 | 2024 | |
| Abbvie INC. | $22.44 | 2023 | Botox |
| Amgen INC. | $14.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.